Delta 9 Cannabis recently suffered a steep negative correlation. However, this was given market resistance. Now the potential of a small breakout or positive spread seems likely to happen. They are a small cap producer, but market demand for their product in the medical cannabis world seems to be growing. A price around CA$1.50 seems reasonable within the next few weeks or as a short target. Now in terms of risk, it is still a small company with little media attention. They are also a minimal producer. Even listed on the exchanges, it is one of the smaller suppliers. The risk is obviously high, but it is still investable for a portfolio.